All articles by Johney


Takeda sells select products portfolio to Hypera Pharma

Japanese company Takeda Pharmaceutical has completed the previously announced sale of select over-the-counter (OTC) and non-core assets in Latin America to Hypera Pharma for $825m.

Serum Institute of India plans clinical trials of second Covid-19 vaccine

Serum Institute of India (SII) has announced plans to conduct clinical trials of another Covid-19 vaccine in the country, with hopes to launch it in June.

Elasmogen identifies protein-based drugs to fight Covid-19

Elasmogen has identified protein-based drugs that can potentially stop Covid-19 infections, through a partnership with the University of Minnesota.

Vaccibody signs agreement with Genentech for individualised neoantigen cancer vaccines

Biopharmaceutical company Vaccibody has signed an exclusive worldwide license and collaboration agreement with Genentech for the development and commercialisation of DNA-based individualised neoantigen cancer vaccines.

Ansa raises funds for DNA synthesis technology development

Ansa Biotechnologies has raised $7.9m as part of its oversubscribed seed financing round led by Horizons Ventures, with participation from Humboldt Fund, Mubadala Capital, and other investors.